Gene · 170482
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Venetoclax monotherapy as front-line therapy for blastic plasmacytoid dendritic cell neoplasm. | Leuk Res Rep | 2023 | 38098959 | PubTator, text mining | PubMed |
| Role of the immune system in liver transplantation and its implications for therapeutic interventions. | MedComm (2020) | 2023 | 38098611 | PubTator, text mining | PubMed |
| The Simple prEservatioN of Single cElls method for cryopreservation enables the generation of single-cell immune profiles from whole blood. | Front Immunol | 2023 | 38090590 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals peripheral immune responses in non-segmental vitiligo. | Front Immunol | 2023 | 38077333 | PubTator, text mining | PubMed |
Expansion of CD4+ cytotoxic T lymphocytes with specific gene expression patterns may contribute to suppression of tumor immunity in oral squamous cell carcinoma: single-cell analysis and in vitro experiments. | Front Immunol | 2023 | 38077321 | PubTator, text mining | PubMed |
| Diabetes Mellitus and Gastric Cancer: Correlation and Potential Mechanisms. | J Diabetes Res | 2023 | 38020199 | PubTator, text mining | PubMed |
| High-dimensional single-cell proteomics analysis of esophageal squamous cell carcinoma reveals dynamic alterations of the tumor immune microenvironment after neoadjuvant therapy. | J Immunother Cancer | 2023 | 38016720 | PubTator, text mining | PubMed |
| Deciphering tumor-infiltrating dendritic cells in the single-cell era. | Exp Hematol Oncol | 2023 | 38012715 | PubTator, text mining | PubMed |
| A robust mRNA signature obtained via recursive ensemble feature selection predicts the responsiveness of omalizumab in moderate-to-severe asthma. | Clin Transl Allergy | 2023 | 38006387 | PubTator, text mining | PubMed |
| Leukemia Cutis-The Current View on Pathogenesis, Diagnosis, and Treatment. | Cancers (Basel) | 2023 | 38001655 | PubTator, text mining | PubMed |
| Histopathological Markers for Target Therapies in Primary Cutaneous Lymphomas. | Cells | 2023 | 37998391 | PubTator, text mining | PubMed |
| A tumor-associated heparan sulfate-related glycosaminoglycan promotes the generation of functional regulatory T cells. | Cell Mol Immunol | 2023 | 37990034 | PubTator, text mining | PubMed |
| Development of a proteomic signature associated with severe disease for patients with COVID-19 using data from 5 multicenter, randomized, controlled, and prospective studies. | Sci Rep | 2023 | 37985892 | PubTator, text mining | PubMed |
| Dendritic Cell Subpopulations Are Associated with Prognostic Characteristics of Breast Cancer after Neoadjuvant Chemotherapy-An Observational Study. | Int J Mol Sci | 2023 | 37958800 | PubTator, text mining | PubMed |
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients. | Cancers (Basel) | 2023 | 37958458 | PubTator, text mining | PubMed |
| Interferon ɛ restricts Zika virus infection in the female reproductive tract. | PNAS Nexus | 2023 | 37954158 | PubTator, text mining | PubMed |
| Bcl6 is a subset-defining transcription factor of lymphoid tissue inducer-like ILC3. | Cell Rep | 2023 | 37950867 | PubTator, text mining | PubMed |
| Deep phenotyping of the lipidomic response in COVID-19 and non-COVID-19 sepsis. | Clin Transl Med | 2023 | 37948331 | PubTator, text mining | PubMed |
| A Case of Acute Myeloid Leukemia Mimicking Blastic Plasmacytoid Dendritic Cell Neoplasm: Utility of the Proposed Upcoming WHO-5 Diagnostic Criteria. | Case Rep Hematol | 2023 | 37946878 | PubTator, text mining | PubMed |
| Toll-like receptor 9-positive plasmacytoid dendritic cells promote Th17 immune responses in oral lichen planus stimulated by epithelium-derived cathepsin K. | Sci Rep | 2023 | 37935734 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/170482/papers?page=6